Between 1968 and 1981, 138 patients (101 male and 37 female) with a mean age of 38 years were operated on for chronic pancreatitis at the Department of General Surgery, University of Göttingen. Pathogenetic factors were alcohol abuse in 65%, biliary diseases in 14% and unknown in 20%. Surgical therapy included 51 resections (37%) (4 total pancreatectomies, 24 Whipple’s procedures and 23 left pancreatectomy). Drainage operations were performed in 68 patients (49%) (24 pancreaticojejunostomies and 44 cystojejunostomies). Intervention of neighboring organs were performed 23 times. The mean follow-up period was 10 years (4–14 years), the late mortality rate in drainage operations (15 and 19%) was twice as high as after resection procedures (7.5%). Recurrences occurred in 16 % after resections but in 41 % after drainage operations. Latent or manifest diabetes was observed in 21 % after drainage operations but in 63% in the resection group. From these data we conclude that both alcohol withdrawal and the type of planned operations are important factors in the prognosis of chronic pancreatitis.

Keywords:
Chronic pancreatitis, Surgical therapy, Long-term results
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.